{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:12:19Z","timestamp":1781579539973,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.gene.2013.08.045","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T21:15:18Z","timestamp":1377638118000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: Impact on susceptibility and response to steroids"],"prefix":"10.1016","volume":"530","author":[{"given":"Doaa M.","family":"Youssef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek A.","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal S.","family":"El-Shal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzya A.","family":"Abduelometty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2013.08.045_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000045609","article-title":"Predictive value of repeat renal biopsies in children with nephrotic syndrome","volume":"84","author":"Ahmad","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.gene.2013.08.045_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00008571-200104000-00005","article-title":"MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity","volume":"11","author":"Ameyaw","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.08.045_bb0015","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000073901.94759.36","article-title":"Association of the multidrug esistance-1 gene single nucleotide polymorphisms with the tacrolimus dose requirement in renal transplant recipients","volume":"14","author":"Anglicheau","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.gene.2013.08.045_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gene.2013.08.045_bb0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1067\/mcp.2001.114164","article-title":"Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects","volume":"69","author":"Cascorbi","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.gene.2013.08.045_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.arcped.2008.11.018","article-title":"Treatment of steroid-resistant idiopathic nephritic syndrome","volume":"16","author":"Chemli","year":"2009","journal-title":"Arch. Pediatr."},{"issue":"9","key":"10.1016\/j.gene.2013.08.045_bb0035","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00467-012-2182-0","article-title":"Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome","volume":"27","author":"Chiou","year":"2012","journal-title":"Pediatr. Nephrol."},{"issue":"11","key":"10.1016\/j.gene.2013.08.045_bb0040","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00467-011-1903-0","article-title":"Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome","volume":"26","author":"Choi","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.gene.2013.08.045_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood\u2013brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.gene.2013.08.045_bb0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/08860220701573624","article-title":"Steroid responsiveness of children with idiopathic nephrotic syndrome in the southeastern region of Turkey","volume":"29","author":"Davutoglu","year":"2007","journal-title":"Ren. Fail."},{"key":"10.1016\/j.gene.2013.08.045_bb0055","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00054725-200409000-00012","article-title":"Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein","volume":"10","author":"Dilger","year":"2004","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.gene.2013.08.045_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007691-200404000-00017","article-title":"Clinical aspects of the MDR1 (ABCB1) gene polymorphism","volume":"26","author":"Eichelbaum","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.gene.2013.08.045_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00467-011-1851-8","article-title":"Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature","volume":"26","author":"El Bakkali","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.gene.2013.08.045_bb0075","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.ki.5000245","article-title":"The relationship among nephrin, podocin, CD2AP and a-actinin might not be a true interaction in podocyte","volume":"69","author":"Fan","year":"2005","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.gene.2013.08.045_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1542\/peds.2008-1559","article-title":"Management of childhood onset nephrotic syndrome","volume":"124","author":"Gipson","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.gene.2013.08.045_bb0085","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1023\/A:1013177710941","article-title":"Anti-P-glycoprotein antibody induced apoptosis of activated peripheral blood lymphocytes: a possible role of P-glycoprotein in lymphocyte survival","volume":"21","author":"Gollapud","year":"2001","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.gene.2013.08.045_bb0090","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.4238\/vol7-4gmr496","article-title":"Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population","volume":"7","author":"Gumus-Akay","year":"2008","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.gene.2013.08.045_bb0095","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","volume":"105","author":"Hogg","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.gene.2013.08.045_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200443090-00001","article-title":"The MDR1 (ABCB1) gene polymorphism and its clinical implications","volume":"43","author":"Ieiri","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.gene.2013.08.045_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone","volume":"98","author":"International Study of Kidney Disease in Children","year":"1981","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2013.08.045_bb0110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-3476(82)80692-6","article-title":"Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children","volume":"101","author":"International Study of Kidney Disease in Children","year":"1982","journal-title":"J. Pediatr."},{"issue":"12","key":"10.1016\/j.gene.2013.08.045_bb0115","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1093\/ndt\/gfr150","article-title":"MDR-1 gene polymorphisms in steroid-responsive versus steroid resistant nephrotic syndrome in children","volume":"26","author":"Jafar","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.gene.2013.08.045_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mcp.2001.117412","article-title":"Identification of functionally variant MDR1 alleles among European Americans and African Americans","volume":"70","author":"Kim","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.gene.2013.08.045_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/ecam\/nep118","article-title":"Association between genetic polymorphism of multidrug resistance 1 gene and Sasang constitutions","volume":"6","author":"Kim","year":"2009","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.gene.2013.08.045_bb0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.gene.2013.08.045_bb0135","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood.V83.9.2451.2451","article-title":"P-glycoprotein expression and function in circulating blood cells from normal volunteers","volume":"83","author":"Klimecki","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.gene.2013.08.045_bb0140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00008571-200308000-00006","article-title":"Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene","volume":"13","author":"Kroetz","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.08.045_bb0145","first-page":"35","article-title":"Frequency of common MDR1 gene variants in a Polish population","volume":"58","author":"Kurzawski","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.gene.2013.08.045_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2003.tb01344.x","article-title":"The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis related factors in human malignancies","volume":"94","author":"Kuwano","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.gene.2013.08.045_bb0155","first-page":"1258","article-title":"Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes","volume":"24","author":"Raghu","year":"1996","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.gene.2013.08.045_bb0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2003.08.002","article-title":"P-glycoprotein in autoimmune diseases","volume":"3","author":"Richaud-Patin","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.gene.2013.08.045_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2133\/dmpk.20.391","article-title":"MDR1 genotype-related pharmacokinetics: fact or fiction?","volume":"20","author":"Sakaeda","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.gene.2013.08.045_bb0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1517\/phgs.4.4.397.22747","article-title":"Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs","volume":"4","author":"Sakaeda","year":"2003","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.gene.2013.08.045_bb0165","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2174\/1568026043387692","article-title":"Pharmacogenetics of drug transporters and its impact on the pharmacotherapy","volume":"4","author":"Sakaeda","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.gene.2013.08.045_bb0180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.pharmtox.43.100901.140233","article-title":"Genetic polymorphisms of the human MDR1 drug transporter","volume":"43","author":"Schwab","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.gene.2013.08.045_bb0185","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/01.ASN.0000019412.87412.BC","article-title":"Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors","volume":"13","author":"Siegsmund","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.gene.2013.08.045_bb0190","first-page":"218","article-title":"Resistance to therapy in primary nephritic syndrome: effect of MDR1 gene activity","volume":"8","author":"Stachowski","year":"2000","journal-title":"Pol. Merkur. Lek."},{"key":"10.1016\/j.gene.2013.08.045_bb0195","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1124\/jpet.104.069724","article-title":"Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene","volume":"311","author":"Takane","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.08.045_bb0200","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.08.045_bb0205","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1365-2443.2004.00803.x","article-title":"Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes","volume":"9","author":"Tsujimura","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.gene.2013.08.045_bb0210","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00467-006-0275-3","article-title":"MDR-1 gene polymorphisms and clinical course of steroid-responsive nephritic syndrome in children","volume":"22","author":"Wasilewska","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.gene.2013.08.045_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1389200043489108","article-title":"The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function","volume":"5","author":"Woodahl","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.gene.2013.08.045_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000156488","article-title":"Impact of MDR1 haplotypes derived from C1236T, G2677T\/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers","volume":"82","author":"Xu","year":"2008","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.gene.2013.08.045_bb0060","first-page":"1","article-title":"Multidrug resistance-1 gene polymorphisms in steroid resistance nephrotic syndrome with different pathology","volume":"1","author":"Youssef","year":"2013","journal-title":"Am. J. Med. Stud."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913010883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913010883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T17:17:35Z","timestamp":1596388655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913010883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0378111913010883"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.08.045","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: Impact on susceptibility and response to steroids","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2013.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}